Dietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Converging Mechanisms, Interactions, and Strategies for Durable Weight Control
Yuxin Wang, Jiaxin Liu, Kristin Verbeke, Naschla Gasaly Retamal, Renate Akkerman, Paul de Vos · 2026
Read Dietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Converging Mechanisms, Interactions, and Strategies for Durable Weight Control by Yuxin Wang, Jiaxin Liu, Kristin Verbeke, Naschla Gasaly Retamal, Renate Akkerman, Paul de Vos (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13234238.txt.
Description
Wang and co-authors weigh dietary fiber beside GLP-1 receptor drugs for obesity care. These drugs have reshaped obesity treatment with large, lasting weight loss for many patients. Yet nausea, vomiting, and constipation are common, dose-linked effects that often make people stop treatment, and weight regain is typical.
Fiber works through gut routes that overlap with how these drugs act. The review maps where fiber and the drugs converge and where they may clash. It sets out tactics that pair both tools for steadier weight control, aiming to ease side effects and slow regain after drug doses end.
Catalog record
| CREATOR | Yuxin Wang, Jiaxin Liu, Kristin Verbeke, Naschla Gasaly Retamal, Renate Akkerman, Paul de Vos |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 77 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |